Cargando…
Behavior of total alkaline phosphatase after radium-233 therapy in metastatic castration-resistant prostate cancer: a single-center, real-world retrospective study
OBJECTIVE: To describe the behavior of total alkaline phosphatase (tALP) in patients with metastatic castration-resistant prostate cancer receiving radium-223 therapy, in a real-world scenario, and to describe overall survival (OS) among such patients. MATERIALS AND METHODS: This was a retrospective...
Autores principales: | Lopes, Flávia Paiva Proença Lobo, Pedras, Marcos Villela, Ferreira, Álida Rosária Silva, Ledesma, Patricia Massucheto, Dias, Paulo Roberto Telles Pires, Pedras, Felipe Villela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Publicação do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411772/ https://www.ncbi.nlm.nih.gov/pubmed/37564085 http://dx.doi.org/10.1590/0100-3984.2022.0080 |
Ejemplares similares
-
Insights into the prognostic potential of total alkaline phosphatase
in metastatic castration-resistant prostate cancer treated with
radium-223
por: Viani, Gustavo
Publicado: (2023) -
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
por: van der Doelen, Maarten J., et al.
Publicado: (2021) -
Fluorescence in industry
por: Pedras, Bruno
Publicado: (2019) -
Radium-223 in metastatic castration resistant prostate cancer
por: Vuong, Winston, et al.
Publicado: (2014) -
Radium-223 for the treatment of castration-resistant prostate cancer
por: El-Amm, Joelle, et al.
Publicado: (2015)